- Home
- YALA vs ABSI Comparison
YALA vs ABSI Comparison
Compare YALA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YALA | ABSI |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 886.7M | 997.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | YALA | ABSI |
|---|---|---|
| Price | $5.54 | $7.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.96 |
| AVG Volume (30 Days) | 344.7K | ★ 4.4M |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $16.40 | $215.96 |
| Revenue Next Year | $7.13 | $319.10 |
| P/E Ratio | $8.76 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.23 | $2.24 |
| 52 Week High | $9.29 | $7.39 |
Technical Indicators
Market Signals| Indicator | YALA | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 63.31 |
| Support Level | N/A | $2.51 |
| Resistance Level | $7.27 | N/A |
| Average True Range (ATR) | 0.19 | 0.65 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 26.09 | 88.46 |
Price Performance
Historical ComparisonAbout YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The group has one operating segment, which is the social networking and entertainment platform.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.